Overview
Micro- and nanoplastics are increasingly being detected in human tissues such as blood, stool, bile, and, more recently, the liver. Although exposure is now recognised as widespread, we still lack a clear understanding of how many particles accumulate in the body, where they reside, and whether they contribute to liver disease.
The ANTHEM project addresses this critical gap by developing robust, sensitive laboratory methods to detect and quantify micro- and nanoplastics in human biological samples and determine whether their presence is linked to liver pathology. This work will deliver the first systematic assessment of plastic particle burden across different stages of liver disease, including cancer progression and historical exposure trends.